Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer launches Healthcare Hub to support healthtech startups

April 19, 2017
Medical Communications, Research and Development HealthTech, Pfizer, healthcare

Pfizer has announced the launch of ‘Pfizer Healthcare Hub: London’, a project that aims to help startups, focusing on the …

News
three_syringes

Old antibiotic nears new FDA approval after positive trials

April 7, 2017
Medical Communications, Research and Development Pfizer, Zavante, Zolyd, antibiotic

Zavante, a biotech company based in San Diego, has unveiled positive results from a recent Phase II/III trials that could …

News

Pfizer resolves pension dispute at Irish facility

April 5, 2017
Manufacturing and Production, Research and Development Ireland, Pfizer, Siptu

Pfizer and trade union Siptu have reached an agreement over a pension dispute at the company’s plant at Ringaskiddy in …

News

Pfizer secures expanded approval for Ibrance

April 3, 2017
Sales and Marketing Pfizer, ibrance

Pfizer has announced that FDA has approved its supplemental New Drug Application (sNDA) for Ibrance, meaning that the drug is …

News
figure-1691868_960_720

Pfizer receive European approval for arthritis drug

March 27, 2017
Sales and Marketing Pfizer, rheumatoid arthritis

Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given …

News
merck_kgaa_pyramid_use_with_credit

Merck KGaA and Pfizer enter the immunotherapy market with Bavencio

March 27, 2017
Sales and Marketing Bavencio, Merck KGaA, Pfizer

Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in …

News

Advent reportedly backs out of bid for Pfizer’s Brazil plant

March 23, 2017
Sales and Marketing Brazil, Pfizer, generics

It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

News
pfizer_brussels

Pfizer announces partnership with UK university

March 13, 2017
Medical Communications, Sales and Marketing Pfizer, Swansea University

Pfizer and Swansea University have announced plans to collaborate on a new Innovation Hub at Swansea University’s new £450 million …

News

Pfizer plant receives FDA warning letter for contamination of medicine

March 1, 2017
Manufacturing and Production Copaxone, Mylan, Pfizer, Teva, generics

The FDA has issued a warning letter to Pfizer after inspectors discovered that the plant did not protect properly against …

News
pfizer_brussels

Pfizer’s Remicade biosimilar displays similar efficacy

February 22, 2017
Research and Development Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer and Celltrion have announced new data for their Remicade biosimilar, Inflectra, that shows that the drug is comparable in …

News

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017
Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …

News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …

Feature

NICE rejects Pfizer’s first-in-class breast cancer drug

February 3, 2017
Medical Communications, Sales and Marketing NICE, Pfizer, breast cancer

NICE has published draft guidelines which reject Pfizer’s Ibrance (palbociclib) based primarily on the cost of the drug but also …

News

Hospira in US-wide recall of product due to contamination

January 25, 2017
Medical Communications Contamination, Hospira, Pfizer

Hospira, a company owned by Pfizer, has been forced to recall a batch of injectable drugs due to “the presence …

News
access_accelerated

22 pharma companies join forces for global non-communicable disease initiative

January 18, 2017
Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda

The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026